...
首页> 外文期刊>Lab on a chip >Flow-focusing regimes for accelerated production of monodisperse drug-loadable microbubbles toward clinical-scale applications
【24h】

Flow-focusing regimes for accelerated production of monodisperse drug-loadable microbubbles toward clinical-scale applications

机译:流聚焦机制可加速单分散药物可装载微气泡的生产,并朝着临床规模的应用发展

获取原文
获取原文并翻译 | 示例
           

摘要

Ultrasound imaging often calls for the injection of contrast agents, micron-sized bubbles which echo strongly in blood and help distinguish vascularized tissue. Such microbubbles are also being augmented for targeted drug delivery and gene therapy, by the addition of surface receptors and therapeutic payloads. Unfortunately, conventional production methods yield a polydisperse population, whose nonuniform resonance and drug-loading are less than ideal. An alternative technique, microfluidic flow-focusing, is able to produce highly monodisperse microbubbles with stabilizing lipid membranes and drug-carrying oil layers. However, the published 1 kHz production rate for these uniform drug bubbles is very low compared to conventional methods, and must be improved before clinical use can be practical. In this study, flow-focusing production of oil-layered lipid microbubbles was tested up to 300 kHz, with coalescence suppressed by high lipid concentrations or inclusion of Pluronic F68 surfactant in the lipid solution. The transition between geometry-controlled and dripping production regimes was analysed, and production scaling was found to be continuous, with a power trend of exponent ~5/12 similar to literature. Unlike prior studies with this trend, however, scaling curves here were found to be pressure-dependent, particularly at lower pressure-flow equilibria (e.g. <15 psi). Adjustments in oil flow rate were observed to have a similar effect, akin to a pressure change of 1-3 psi. This analysis and characterization of high-speed dual-layer bubble generation will enable more-predictive production control, at rates practical for in vivo or clinical use.
机译:超声成像通常要求注射造影剂,微米级气泡,这些气泡在血液中强烈回声并有助于区分血管组织。通过添加表面受体和治疗有效载荷,还可以增加此类微泡用于靶向药物递送和基因治疗。不幸的是,传统的生产方法会产生多分散的种群,其不均匀的共振和载药量都不理想。另一种技术是微流体流动聚焦,它能够产生具有稳定脂质膜和载药油层的高度单分散的微气泡。但是,与常规方法相比,这些均一的药物气泡的已公布的1 kHz生产率非常低,必须加以改进,然后才能临床应用。在这项研究中,测试了高达300 kHz的油层脂质微泡的流动聚集生产,并通过高脂质浓度或在脂质溶液中包含Pluronic F68表面活性剂抑制了聚结。分析了几何控制和滴灌生产方式之间的转换,发现生产规模是连续的,其幂趋势为〜5/12,与文献相似。但是,与先前具有这种趋势的研究不同,这里的比例曲线被发现是压力相关的,特别是在较低的压力-流量平衡时(例如<15 psi)。观察到油流量的调整具有类似的效果,类似于1-3 psi的压力变化。高速双层气泡产生的这种分析和表征将能够以体内或临床实际使用的速率实现更具预测性的生产控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号